Anticogulants in clinical practice;Anticoagulants et leur maniement

Revue du Praticien

Volumn 49, Issue 15, 1999, Pages 1641-1647

  Boneu, Bernard ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTIVITAMIN K; CARDIOVASCULAR AGENT; COLESTYRAMINE; DALTEPARIN; DANAPAROID; DIGESTIVE TRACT AGENT; ENOXAPARIN; FLUINDIONE; HEPARIN; HEPARIN CALCIUM; HIRUDIN; NADROPARIN; NEUROLEPTIC AGENT; PHENINDIONE; PROTAMINE; REVIPARIN; TAMOXIFEN; TINZAPARIN; TIOCLOMAROL; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTINUOUS INFUSION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MONITORING; DRUG POTENTIATION; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; THROMBOSIS;

ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; HEPARIN; HEPARITIN SULFATE; HIRUDIN THERAPY; HUMANS; THROMBOCYTOPENIA; VITAMIN K;

EID: 0033215109     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Cazaux V, Gauthier B, Ellas A et al. Predicting daily maintenance of fluindione, an oral anticoagulant drug.Thromb Haemostas 1996 ; 75 : 731-3.
2. Fennerty A, Dolben J, Thomas P et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. BMJ 1984 ; 228 : 1268-70.
3. ra partie).
4. e partie).
5. Hirsh J, Dalen JE, Anderson DR et al. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998 ; 114 (suppl.) : 445S-469S.
6. Hirsh J, Warkentin TE, Raschke R, Granger C, Magnus Ohman E, Dalen JE. Heparin and low-molecular-weight heparin.Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and Sagety. Chest 1998 ; 114 (suppl.) : 489S-510S.
7. Recommandations du Groupe d'études sur l'hémostase et la thrombose (GEHT).Utilisation des traitements antithrombotiques en pratique médicale courante. STV octobre 1996 ; numéro spécial ; 1-43.